Objective: To characterize the stomatognathic system and stomatognathic functions in patients with mucopolysaccharidosis.
Introduction

Mucopolysaccharidoses (MPS) are genetic diseases
caused by the deficient activity of enzymes that degrade glycosaminoglycans (GAGs) and by the consequent accumulation of these macromolecules inside lysosomes. 1 The Each type of MPS is associated with great clinical heterogeneity. As to MPS I, for instance, its most severe form (characterized by mental retardation, severe somatic involvement and death before the age of 10 years) is usually called Hurler syndrome. Its mild form (characterized by preserved cognition and less somatic involvement) is called Scheie syndrome. 3 In all MPS types, the following findings are frequent: macrocephaly, hepatosplenomegaly, umbilical and inguinal hernias, bone dysplasia, delayed motor development, hearing loss, respiratory difficulty, facial and dental alterations, enlarged tongue, heart disease, and limitation of joint mobility. Corneal clouding is not frequent in MPS II, III and IV; MPS IV and VI are not usually associated with mental retardation. [4] [5] [6] MPS treatment may be symptomatic or specific.
Symptomatic treatment addresses the disease complications,
such as the use of medication for heart insufficiency. The specific treatment seeks to replace the deficient enzyme, and includes when recommended hematopoietic cells transplantation and enzyme replacement therapy (ERT); the latter is available for MPS I, II and VI. [10] [11] [12] In the literature there are few studies regarding speech and language evaluation in patients with MPS, and most are focused on aspects related to speech and language development. [13] [14] [15] The main objective of this study was to describe the alterations found in the stomatognathic system and functions of patients with MPS.
Methods
This is a cross-sectional and observational study, patients, all with MPS VI. Two patients had a tracheotomy tube (both had MPS VI). MPS I, II and VI each accounted for more than 10% of the total sample, and were included in subgroup analysis. During the evaluation, 18 patients were receiving phonoaudiological treatment, and 40 were given ERT (at the Medical Genetics Service of HCPA).
Anamnesis
In terms of maternal breastfeeding, 62/76 (81.6%) . In another patient only the stomatognathic system could be evaluated. Therefore, of the 78 patients included in the study, 77 had their stomatognathic structures evaluated and 76 had their stomatognathic functions evaluated. † Habitual position represents the position at rest in which lips, tongue and dental arch are found. ‡ Only variables that could be evaluated for more than 50% of the sample are described.
As a consequence, mean diagnostic age in Brazilian patients (76 months) is higher than the double of that found in developed countries. 21 Since the pediatrician is the health professional most frequently sought by patients/relatives with MPS when clinical manifestations occur, 21 . In another patient only the stomatognathic system could be evaluated. Therefore, of the 78 patients included in the study, 77 had their stomatognathic structures evaluated and 76 had their stomatognathic functions evaluated. ‡ Only variables that could be evaluated for more than 50% of the sample are described. Considering patients with MPS I, II and VI submitted or not to ERT, there was statistically significant difference in relation to oral breathing, which was more frequent in the group not exposed to ERT. One limitation of such finding is that data collection and analysis were not blinded. However, it is in accordance with data from the literature, which suggest a positive clinical effect of ERT on upper airways. [10] [11] [12] A small number of patients were undergoing speech therapy during the study period. Among the possible reasons for that are difficulty to access this form of treatment; lack of knowledge of the high prevalence of speech abnormalities in patients with MPS by assistant physicians; and absence of evidence on the benefits of such intervention. 15 The rational of speech therapy treatment for orofacial motricity in patients with MPS would be that, if applied correctly, it would increase muscle tonus, change some functional patterns and prevent deviations in craniofacial development. also, the sooner Speech and language evaluation in mucopolysaccharidosis -Turra GS & Schwartz IV the diagnosis of these patients is established more the phonoaudiologist will be able to help prevent certain clinical manifestations of this disease. In this manner, guidance to parents, especially in issues such as breastfeeding and mastication of adequate food consistency could perhaps reduce the frequency of some of the findings of the present study. These hypotheses should be confirmed by future studies.
In general, the data obtained in this study reinforce the circular relationship "cause-effect-cause-effect" present in MPS: the high frequency of alterations in structures of the stomatognathic system is associated with a high frequency of alterations in stomatognathic functions, which in turn can worsen structural alterations. In the authors' opinion, only a combined and coordinated action by all health professionals involved in providing care to patients with MPS can break this circular relationship and provide better quality of life to patients.
